The peri-operative management of anti-platelet therapy in elective, non-cardiac surgery

被引:5
|
作者
Alcock, Richard F. [1 ]
Naoum, Chris [1 ]
Aliprandi-Costa, Bernadette [1 ]
Hillis, Graham S. [1 ]
Brieger, David B. [1 ]
机构
[1] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2006, Australia
关键词
Peri-operative; Anti-platelet therapy; Elective non-cardiac surgery; CORONARY-ARTERY-DISEASE; CARDIAC RISK; MYOCARDIAL-INFARCTION; VASCULAR-SURGERY; ASPIRIN; MORTALITY; VALIDATION; PREDICTORS; PREVENTION; GUIDELINES;
D O I
10.1016/j.ijcard.2011.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiovascular complications are important causes of morbidity and mortality in patients undergoing elective non-cardiac surgery, with adverse cardiac outcomes estimated to occur in approximately 4% of all patients. Anti-platelet therapy withdrawal may precede up to 10% of acute cardiovascular syndromes, with withdrawal in the peri-operative setting incompletely appraised. Objectives: The aims of our study were to determine the proportion of patients undergoing elective noncardiac surgery currently prescribed anti-platelet therapy, and identify current practice in peri-operative management. In addition, the relationship between management of anti-platelet therapy and perioperative cardiac risk was assessed. Methods: We evaluated consecutive patients attending elective non-cardiac surgery at a major tertiary referral centre. Clinical and biochemical data were collected and analysed on patients currently prescribed antiplatelet therapy. Peri-operative management of anti-platelet therapy was compared with estimated perioperative cardiac risk. Results: Included were 2950 consecutive patients, with 516 (17%) prescribed anti-platelet therapy, primarily for ischaemic heart disease. Two hundred and eighty nine (56%) patients had all anti-platelet therapy ceased in the peri-operative period, including 49% of patients with ischaemic heart disease and 46% of patients with previous coronary stenting. Peri-operative cardiac risk score did not influence anti-platelet therapy management. Conclusions: Approximately 17% of patients undergoing elective non-cardiac surgery are prescribed anti-platelet therapy, the predominant indication being for ischaemic heart disease. Almost half of all patients with previous coronary stenting had no anti-platelet therapy during the peri-operative period. The decision to cease antiplatelet therapy, which occurred commonly, did not appear to be guided by peri-operative cardiac risk stratification. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 50 条
  • [41] Preoperative evaluation of adult patients undergoing elective, non-cardiac surgery.
    Geldner, G.
    Mertens, E.
    Wappler, F.
    Zwissler, B.
    Kelm, M.
    Leschke, M.
    Meyer, C.
    Moessner, J.
    Obertacke, U.
    Schwenk, W.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2010, 51 : S788 - S797
  • [42] A survey of peri-operative use of magnesium sulphate in adult cardiac surgery in the UK
    Roscoe, A
    Ahmed, AB
    ANAESTHESIA, 2003, 58 (04) : 363 - 365
  • [43] Dual anti-platelet therapy and dento-alveolar surgery. How do we manage patients on anti-platelet medication?
    Patel, N.
    Patel, V.
    Sarkar, D.
    Nokes, T.
    Blacklock, P.
    BRITISH DENTAL JOURNAL, 2014, 217 (11) : E24 - E24
  • [44] Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery
    Cohen Arazi, Hernan
    Doiny, David G.
    Spampinato Torcivia, Ricardo
    Grancelli, Hugo
    Waldman, Silvina V.
    Nojek, Carlos
    Cecilia Fornari, Maria
    Badimon, Juan Jose
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2010, 10 (06) : 863 - 867
  • [45] Peri-operative anaemia management in major orthopaedic surgery: the need to find a pathway
    Munoz, Manuel
    Gomez-Ramirez, Susana
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2017, 15 (04) : 289 - 291
  • [46] Platelet function assessed by whole-blood aggregometry in patients undergoing non-cardiac surgery
    Oscarsson, Anna
    Oster, Susanne
    Fredrikson, Mats
    Lindahl, Tomas L.
    Eintrei, Christina
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2011, 28 (05) : 363 - 369
  • [47] Cardiac complications of major elective non-cardiac surgery:: Incidence and risk factors
    Puig-Barbera, Joan
    Marquez-Calderon, Soledad
    Vila-Sanchez, Miguel
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (04): : 329 - 337
  • [48] Perioperative Management of Patients With Pulmonary Hypertension for Non-Cardiac Surgery
    Yang, Elaine I.
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (03)
  • [49] Myocardial injury after non-cardiac surgery: diagnosis and management
    Devereaux, P. J.
    Szczeklik, Wojciech
    EUROPEAN HEART JOURNAL, 2020, 41 (32) : 3083 - 3091
  • [50] The correlation between peri-operative hyperglycemia and mortality in cardiac surgery patients: a systematic review
    Giakoumidakis, Konstantinos
    Nenekidis, Ioannis
    Brokalaki, Hero
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2012, 11 (01) : 105 - 113